Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM3B | Q7LBC6 | 1/20 | 0.65 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.33 |
| ▸ | UBE2N | P61088 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | SLC22A4 | Q9H015 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12872720 | 0.73 | KDM3B (0.62) | KDM3BKMT2ATDP1MEN1RXFP1 | |
| SCHEMBL10001205 | 0.73 | KDM3B (0.62) | KDM3BKMT2ATDP1MEN1RXFP1 | |
| SCHEMBL1810204 | 0.69 | KMT2A (0.61) | KDM3BKMT2ATDP1MEN1KDM4E | |
| SCHEMBL21345242 | 0.68 | KDM3B (0.47) | KDM3BKMT2ATDP1MEN1RXFP1 | |
| SCHEMBL25418259 | 0.63 | ATAD2 (0.60) | KDM3BKMT2ATDP1MEN1RXFP1 | |
| SCHEMBL10509279 | 0.63 | — | — | |
| SCHEMBL25450 | 0.63 | — | — | |
| SCHEMBL3321070 | 0.63 | — | — | |
| SCHEMBL11739894 | 0.63 | — | — | |
| SCHEMBL1227831 | 0.63 | KMT2A (0.62) | KDM3BKMT2ATDP1MEN1RXFP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11013668-B2 | Two-package dental adhesive composition | TOKUYAMA DENTAL CORPORATION | 2021-05-25 | — | — | US | disclosed |
| US-20190240117-A1 | TWO-PACKAGE DENTAL ADHESIVE COMPOSITION | TOKUYAMA DENTAL CORPORATION (JP) | 2019-08-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11013668-B2 | Two-package dental adhesive composition | ITGB2, ITGA2, ITGA2B | KDM3B 2920/4885KMT2A 1422/4885TDP1 4278/4885 |
| US-20190240117-A1 | TWO-PACKAGE DENTAL ADHESIVE COMPOSITION | ITGB2, ITGA2, ITGA2B | KDM3B 2920/4885KMT2A 1422/4885TDP1 4278/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.